Melinda L. Telli, MD, will deliver the second plenary lecture at the 2023 SABCS® on how the emergence of immunotherapy and antibody drug conjugation has changed the field of triple-negative breast cancer and increased options for patients.

The 2023 SABCS® will feature multiple presentations on breast cancer risk reduction and prevention, including a discussion of obesity-associated breast cancer risk moderated by Abenaa M. Brewster, MD, MHS.

Komal Jhaveri, MD, FACP, will moderate a lightning-quick discussion of challenging or controversial topics, including low-dose tamoxifen, window-of-opportunity trials, and tumor sequencing timing.